BioCentury
ARTICLE | Top Story

Protagonist raises $90M in bumped-up IPO

August 11, 2016 7:00 AM UTC

Protagonist Therapeutics Inc. (NASDAQ:PTGX) dipped $0.30 to $11.70 in its first day of trading Thursday after it raised $90 million through the sale of 7.5 million shares at $12 in an IPO. Leerink, Barclays and BMO Capital Markets are underwriters.

Earlier this month, Protagonist said it hoped to sell 5.8 million shares at $11-$13. The company filed last month to raise up to $75 million. ...